BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 20614461)

  • 1. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Liu R; Wang X; Tian JH; Yang K; Wang J; Jiang L; Hao XY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007563. PubMed ID: 25300170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis.
    Lee KK; Lee JY; Nam JM; Kim CB; Park KR
    Brachytherapy; 2015; 14(4):449-57. PubMed ID: 25906951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
    Romano KD; Pugh KJ; Trifiletti DM; Libby B; Showalter TN
    Brachytherapy; 2017; 16(2):378-386. PubMed ID: 28139420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
    Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
    Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008217. PubMed ID: 21491407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
    Gupta IJ; Ghosh A; Yadav J; Tuteja JS; Gupta R; Srivastava K; Verma M; Gupta S; Srivastava S; Bhatt MLB
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3441-3445. PubMed ID: 37898849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
    Lin AJ; Samson P; Zoberi J; Garcia-Ramirez J; Williamson JF; Markovina S; Schwarz J; Grigsby PW
    Brachytherapy; 2019; 18(3):353-360. PubMed ID: 30971370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High versus low-dose rate brachytherapy for cervical cancer.
    Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial.
    Mahantshetty U; Lewis S; Engineer R; Swamidas J; Chopra S; Gurram L; Kinhikar R; Deshpande D; Kirisits C; Shrivastava S
    Brachytherapy; 2021; 20(6):1146-1155. PubMed ID: 34598883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
    Scott AA; Yarney J; Vanderpuye V; Akoto Aidoo C; Agyeman M; Boateng SN; Sasu E; Anarfi K; Obeng-Mensah T
    Int J Gynecol Cancer; 2021 May; 31(5):670-678. PubMed ID: 33558421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study to evaluate dosimetric differences in patients of locally advanced carcinoma cervix undergoing intracavitary brachytherapy under two different anaesthesia techniques: an audit from a tertiary cancer centre in India.
    Kumar D; Srinivasa GY; Gupta A; Rai B; Oinam AS; Bansal P; Ghoshal S
    J Egypt Natl Canc Inst; 2019 Nov; 31(1):5. PubMed ID: 32372231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation.
    Teo BK; Bonner Millar LP; Ding X; Lin LL
    Radiother Oncol; 2015 May; 115(2):195-202. PubMed ID: 26002306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
    Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
    Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
    Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L
    Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and chemoradiation after surgery for early cervical cancer.
    Rogers L; Siu SS; Luesley D; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD007583. PubMed ID: 22592722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.